Ovintiv Shorts Rise Ahead of Q3 Print

OVV reports third-quarter results on November 3, and the most striking development ahead of the print is a sharp build in short interest against a stock that has rallied 23% over the past month.

Short positioning has grown meaningfully in a short window. Shares short rose 21.5% over the past week to roughly 12.5 million shares, equivalent to 4.9% of the free float. That puts short interest at its highest level in the 30-day window captured in ORTEX data, having climbed from around 9.3 million shares in early October. The move is notable precisely because it runs counter to the stock's momentum. OVV added 23% in October to close at $72.62, outpacing close peers including PR, APA, and DVN, which gained between 4% and 5% on the week. The borrowing market does not suggest a crowded short, however. Availability is extremely loose at roughly 5,800% of short interest, meaning the pool of shares available to borrow dwarfs what is actually lent out. Cost to borrow has also fallen sharply, down 43% over the week to 0.33%. That combination points to shorts entering comfortably rather than under pressure.

Options traders are not positioned defensively. The put/call ratio is 0.46, nearly a full standard deviation below its 20-day average of 0.53, sitting close to the cheapest end of its one-year range. That skew toward calls suggests the options market sees more upside to play than downside to hedge, a contrast to the directional bet embedded in the rising short interest.

The analyst community has moved broadly higher on price targets in October, though the consensus remains split on conviction. Goldman Sachs raised its target to $72 from $65 this week while keeping a Buy rating, with the stock now trading roughly at that level. RBC Capital holds the most bullish target on the Street at $90, reiterating Outperform. Morgan Stanley and Stephens kept more cautious Equal-Weight ratings, with Morgan Stanley's target at $71, a fraction below the current price. The bull case rests on Ovintiv's two-basin Permian and Montney portfolio, roughly 15 to 20 years of inventory depth in each, and technology-driven well productivity gains that have held drilling costs below $600 per foot. The bear case is simpler: earnings and free cash flow remain tightly tethered to commodity prices, and at a 0.8x downside NAV multiple the stock offers limited protection if prices weaken from here.

One institutional move worth flagging: Capital Research and Management added over 14 million shares in the quarter to September 30, taking its stake to 7.1% of the company. T. Rowe Price added nearly 1.9 million shares in the same period, bringing its holding to 3.3%. Both moves represent meaningful conviction increases from active managers ahead of the earnings date. Separately, the only open-market insider transaction in the past 90 days was a sale by an EVP of roughly $491,000 of stock in August, not filed under a 10b5-1 plan, though the size is modest relative to the institutional flow.

The November 3 print will test whether the company's Q3 production and free cash flow numbers justify the October re-rating, and whether the freshly built short interest was positioned correctly for the outcome.